Estimated Effects of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Metformin on Treatment Failure and Survival Outcomes Among Patients With Prostate Cancer Undergoing Hormone Therapy. This evidence concerns the gene SLC5A2 and Familial prostate cancer.